That is necessary, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff bezos). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. This was a breakthrough practically nobody saw. However it's going to have profound implications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of investment chances in this area, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (the legacy report predictions). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps substantially prior to going higher - artificial intelligence. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. tech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of terrific private companies on the brink of hitting the public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This chance has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (jeff brown 1 biotech). And when it concerns tech investing, we leave it to the specialists. Luckily, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we understand (white house). In reality, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential growth and developing incredible opportunities for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. democratic republic. But despite what numerous readers might think, this is a pattern that's just getting going. Even though the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (tech predictions). Losing two months of production and sales actually affects how many 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More importantly, the delays triggered by the pandemic produced a lot of bottled-up need. Which demand is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - self-driving cars. And that's not my only 5G forecast When I have actually talked about 5G in the past, I have actually described its three various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services begin to be offered (future report). That's when we start to see applications working on 5G networks. Believe of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: Many individuals don't actually care about the innovation. But they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next essential innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well understood. And during that time, there were actually only 3 companies running in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is successfully a greenfield chance.
There's space for numerous companies to exist in this area. white house. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software can accurately predict the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That's essential due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been a trial-and-error procedure. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug treatments produced using this technology. This was one of those breakthroughs that almost no one discovered. But it's going to have extensive implications for treating disease. And, obviously, there will be lots of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back perhaps considerably prior to going greater. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin - jeff brown top biotech 2020. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown prediction for 2021. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, but we could not independently verify this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He invested more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a lot of his best choices in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted some of the most significant financial events of the past twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, but Jeff Brown's accurate forecasts have actually made him legions of devoted fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research study offers numerous research services with a wide array of specializations - artificial intelligence.
The company is also connected with Bonner & Partners, another well-respected research publisher - bleeding edge. On its site, Brownstone states its mission is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research has not been readily available to individual investors. It has actually been usually booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown stock predictions 2021. The objective of Brownstone Research study is to make that kind of proprietary research study available to any investors seeking to get an edge in the marketplaces. The objective is easy to deliver special and rewarding financial investment research discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also works as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. brownstone research. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. longtime readers. could be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two advanced innovations: synthetic intelligence and electrical vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automotive industry's Holy Grail. As you understand, electrical automobiles and self-driving car stocks have been big this year, however the Wall Street device has been huge on buzz without much tangible outcome. Regardless of a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Car, and it might be the future of transportation. Generally, this technology would allow you to lease out your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the revenues. It sounds ridiculous, but it could be closed than you believe.